Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Sanara MedTech (SMTI) EPS (Weighted Average and Diluted) (2016 - 2026)

Sanara MedTech posted quarterly EPS (Weighted Average and Diluted) of $0.04 for Q1 2026, up 157.14% year-on-year from $0.02 in Q1 2025, and up 130.77% on a QoQ basis from -$0.13 in Q4 2025.

Sanara MedTech (SMTI) has 10 years of EPS (Weighted Average and Diluted) data on file, last reported at $0.04 in Q1 2026.

  • For the quarter ending Q1 2026, EPS (Weighted Average and Diluted) rose 157.14% year-over-year to $0.04; the trailing twelve-month figure through Mar 2026 stood at -$0.23 (up 67.61% YoY), and the FY2025 full-year result was -$0.05, up 78.26% from the prior year.
  • EPS (Weighted Average and Diluted) for Q1 2026 stood at $0.04, up from -$0.13 in the prior quarter.
  • Across five years, EPS (Weighted Average and Diluted) topped out at $0.11 in Q4 2024 and bottomed at -$0.51 in Q4 2022.
  • The 5-year median for EPS (Weighted Average and Diluted) is -$0.14 (2023), against an average of -$0.14.
  • The widest annual swing landed in 2023, when EPS (Weighted Average and Diluted) plunged 344.44%; it then jumped 466.67% in 2024.
  • A 5-year view of EPS (Weighted Average and Diluted) shows it stood at -$0.51 in 2022, then surged by 94.12% to -$0.03 in 2023, then surged by 466.67% to $0.11 in 2024, then plunged by 218.18% to -$0.13 in 2025, then surged by 130.77% to $0.04 in 2026.
  • The last three EPS (Weighted Average and Diluted) figures came in at $0.04 (Q1 2026), -$0.13 (Q4 2025), and $0.09 (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EPS (Weighted Avg. Diluted) (Qtr)
1 Intuitive Surgical 156.17 Bn 151.78 Bn 1.83 Bn 2.28
2 Becton Dickinson 41.51 Bn 40.49 Bn 2.15 Bn -1.11
3 Resmed 30.43 Bn 28.77 Bn 890.98 Mn 2.74
4 West Pharmaceutical Services 22.78 Bn 22.26 Bn 296.40 Mn 1.92
5 Solventum 13.39 Bn 13.39 Bn 1.10 Bn 0.07
6 Cooper Companies 12.33 Bn 12.20 Bn 695.20 Mn 0.66
7 Align Technology 11.65 Bn 10.59 Bn 736.59 Mn 1.57
8 Baxter International 9.81 Bn 7.77 Bn 891.00 Mn -0.03
9 Aptargroup 7.39 Bn 7.19 Bn 351.91 Mn 1.12
10 Sanara MedTech 203.69 Mn 190.09 Mn 25.87 Mn 0.04

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 0.04
Dec 31, 2025 -0.13
Sep 30, 2025 0.09
Jun 30, 2025 -0.23
Mar 31, 2025 -0.07
Dec 31, 2024 0.11
Sep 30, 2024 -0.34
Jun 30, 2024 -0.41
Mar 31, 2024 -0.21
Dec 31, 2023 -0.03
Sep 30, 2023 -0.13
Jun 30, 2023 -0.22
Mar 31, 2023 -0.14
Dec 31, 2022 -0.51
Sep 30, 2022 -0.18
Jun 30, 2022 0.09
Dec 31, 2020 -0.04
Sep 30, 2020 -0.18
Jun 30, 2020 -0.18
Mar 31, 2020 -0.39
Dec 31, 2019 -0.54
Sep 30, 2019 -0.35
Jun 30, 2019 -0.15
Mar 31, 2019 -0.39
Jun 30, 2018 0.01
Mar 31, 2018 -0.08
Dec 31, 2017 0.00
Sep 30, 2017 0.00
Jun 30, 2017 0.00
Mar 31, 2017 0.00
Dec 31, 2016 0.00
Sep 30, 2016 0.00
Jun 30, 2016 -0.01
Mar 31, 2016 0.00